Biomedical Engineering Reference
In-Depth Information
Table 1
Primer Sequences
Forward (F)/
PCR
Primer
Primer site
Reverse (R)
Sequence (5'-3')
product size
mtF3130
3130-3149
F
AGGACAAGAGAAATAAGGCC
651 bp
mtR3758
3758-3780
R
AGTAGAATGATGGCTAGGGTGAC
mtF8278
8278-8297
F
CTACCCCCTCTAGAGCCCAC
216 bp
mtR8475
8475-8493
R
TTTATCCCGTTTGGTCAGG
mtF8768
8768-8785
F
CAACTAACCTCCTCGGAC
432 bp
mtR9199
9199-9180
R
TGTCGTGCAGGTAGAGGCTT
mtF11688
11688-11705
F
CCGGCGCAGTCATTCTCA
672 bp
mtR12360
12360-12342
R
GGTTATAGTAGTGTGCATG
mtF14437
14437-14455
F
AGGATACTCCTCAATAGCC
748 bp
mtR15185
15202-15185
R
GGCGGATAGTAAGTTTGT
mutations in mitochondrial DNA (mtDNA) and a threshold effect further com-
plicate the diagnosis. Currently, the most commonly known syndromes associ-
ated with specific mtDNA point mutations are myopathy, encephalopathy,
lactic acidosis, and stroke-like episodes (MELAS); myoclonic epilepsy and
ragged red fibers (MERRF); neuropathy, ataxia, and retinitis pigmentosa
(NARP); and Leber's hereditary optic neuropathy (LHON)
(
1-3
)
. A total of 11
point mutations can be analyzed using two single polymerase chain reaction
(PCR) assays and one multiplex PCR containing three pairs of primers. Detec-
tion of these point mutations is achieved by amplification of the DNA regions
containing the point mutations followed by allele-specific oligonucleotide
(ASO) hybridization
(
4
)
.
2. Materials
1.
Extracted genomic DNA from patient's tissues
(
5
,
6
)
.
2.
PCR primers
(
4
,
7
)
. Stock solutions are 100
µ
M
stored in a -20°C freezer. Work-
ing solutions are 10
µ
3.
ASO probes
(
4
,
7
)
. Stock solutions are 100
µ
M
and stored at -20°C. Working
solutions are 10
M
. ASO probes are listed in
Table 2
. The nucleotide positions
where the mutations occur are in bold
(see
Note 1
).
µ
4.
PCR reagents:
a. 10X PCR buffer II (Applied Biosystems, Inc. [ABI]).
b. dNTP 8 m
M
solution.
c. 25 m
M
MgCl
2
.
d. Ampli
Taq
or
Taq
Gold DNA polymerase (ABI).
5.
Church prehybridization and hybridization buffer: 0.5
M
Na
2
HPO
4,
pH 7.2, 1 m
M
ethylenediamine tetraacetic acid (EDTA), and 7% sodium dodecyl sulfate (SDS).